Cargando…

Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn

BACKGROUND: To analyze the effect of different times of pregnancy of type O pregnant women on the occurrence of ABO hemolytic disease of the newborn (ABO-HDN). METHODS: From December 2018 to December 2021, 725 pregnant women with O blood group (husbands with non-O blood group) who met the inclusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zijun, Zhang, Xinhua, Li, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561511/
https://www.ncbi.nlm.nih.gov/pubmed/36247885
http://dx.doi.org/10.21037/tp-22-385
_version_ 1784807961648955392
author Ding, Zijun
Zhang, Xinhua
Li, Hai
author_facet Ding, Zijun
Zhang, Xinhua
Li, Hai
author_sort Ding, Zijun
collection PubMed
description BACKGROUND: To analyze the effect of different times of pregnancy of type O pregnant women on the occurrence of ABO hemolytic disease of the newborn (ABO-HDN). METHODS: From December 2018 to December 2021, 725 pregnant women with O blood group (husbands with non-O blood group) who met the inclusion criteria were collected. There were 116 cases of ABO-HDN, which were summarized and analyzed. The pregnant women were divided into primigravida and non-primigravida groups. The influence of the number of pregnancies on the occurrence of ABO-HDN was compared, and the antibody titer of pregnant women with type O blood was monitored. The relationship between antibody titer and HDN in pregnant women was analyzed by hemolysis test and indirect bilirubin concentration. RESULTS: In the primigravida group, 0 patients with HDN had a titer ≤1:64, 8 (8/26) had a titer of 1:128, 9 (9/20) had a titer of 1:256, 2 (2/4) had a titer of 1:512, and 2 (2/3) had a titer >1:512. In the non-primigravida group, there were 0 cases with a titer ≤1:64, 32 cases (32/78) with a titer of 1:128, and 26 cases (26/46) with a titer of 1:256. The number of cases of ABO incompatibility in maternal and infant groups with different titers of IgG anti-A (B) antibody were 377 cases in the <1:64 group, 130 cases in the 1:64 group, 104 cases in the 1:128 group, 66 cases in the 1:256 group, 32 cases in the 1:512 group, and 16 cases in the >1:512 group. The positive rates of ABO-HDN were 0.0% (0/0), 0.0% (0/0), 38.5% (40/104), 53.0% (35/66), 81.3% (26/32) and 93.8% (15/16), respectively, and the difference was statistically significant (P<0.05). CONCLUSIONS: The occurrence of ABO-HDN was not significantly related to the blood type of the pregnant woman’s husband. Therefore, in order to reduce the degree of hemolysis and avoid the occurrence of bilirubin encephalopathy or even death, pregnant women with antibody titer >1:64 in second or subsequent pregnancies should be closely monitored.
format Online
Article
Text
id pubmed-9561511
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-95615112022-10-15 Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn Ding, Zijun Zhang, Xinhua Li, Hai Transl Pediatr Original Article BACKGROUND: To analyze the effect of different times of pregnancy of type O pregnant women on the occurrence of ABO hemolytic disease of the newborn (ABO-HDN). METHODS: From December 2018 to December 2021, 725 pregnant women with O blood group (husbands with non-O blood group) who met the inclusion criteria were collected. There were 116 cases of ABO-HDN, which were summarized and analyzed. The pregnant women were divided into primigravida and non-primigravida groups. The influence of the number of pregnancies on the occurrence of ABO-HDN was compared, and the antibody titer of pregnant women with type O blood was monitored. The relationship between antibody titer and HDN in pregnant women was analyzed by hemolysis test and indirect bilirubin concentration. RESULTS: In the primigravida group, 0 patients with HDN had a titer ≤1:64, 8 (8/26) had a titer of 1:128, 9 (9/20) had a titer of 1:256, 2 (2/4) had a titer of 1:512, and 2 (2/3) had a titer >1:512. In the non-primigravida group, there were 0 cases with a titer ≤1:64, 32 cases (32/78) with a titer of 1:128, and 26 cases (26/46) with a titer of 1:256. The number of cases of ABO incompatibility in maternal and infant groups with different titers of IgG anti-A (B) antibody were 377 cases in the <1:64 group, 130 cases in the 1:64 group, 104 cases in the 1:128 group, 66 cases in the 1:256 group, 32 cases in the 1:512 group, and 16 cases in the >1:512 group. The positive rates of ABO-HDN were 0.0% (0/0), 0.0% (0/0), 38.5% (40/104), 53.0% (35/66), 81.3% (26/32) and 93.8% (15/16), respectively, and the difference was statistically significant (P<0.05). CONCLUSIONS: The occurrence of ABO-HDN was not significantly related to the blood type of the pregnant woman’s husband. Therefore, in order to reduce the degree of hemolysis and avoid the occurrence of bilirubin encephalopathy or even death, pregnant women with antibody titer >1:64 in second or subsequent pregnancies should be closely monitored. AME Publishing Company 2022-09 /pmc/articles/PMC9561511/ /pubmed/36247885 http://dx.doi.org/10.21037/tp-22-385 Text en 2022 Translational Pediatrics. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Ding, Zijun
Zhang, Xinhua
Li, Hai
Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
title Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
title_full Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
title_fullStr Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
title_full_unstemmed Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
title_short Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
title_sort application of igg antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561511/
https://www.ncbi.nlm.nih.gov/pubmed/36247885
http://dx.doi.org/10.21037/tp-22-385
work_keys_str_mv AT dingzijun applicationofiggantibodytiterandsubtypeindiagnosisandseverityassessmentofhemolyticdiseaseofthenewborn
AT zhangxinhua applicationofiggantibodytiterandsubtypeindiagnosisandseverityassessmentofhemolyticdiseaseofthenewborn
AT lihai applicationofiggantibodytiterandsubtypeindiagnosisandseverityassessmentofhemolyticdiseaseofthenewborn